Simplify Logo

Internship

Summer 2025 – Discovery Chemistry Internship

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Boston, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Three years of chemistry (organic chemistry I/II required) course work at the college level, a strong academic record (≥ 3.0 GPA) and at least three semesters of laboratory course work and research
  • Self-motivated to learn and contribute, demonstrated examples of independent productivity and team-based interpersonal skills
  • Enthusiastic and curious about science, laboratory work and drug discovery
  • Prior chemistry laboratory experience in the academic setting and/or biotechnology/pharmaceutical industry
Responsibilities
  • Literature evaluation of proposed reaction routes
  • Preparation of molecules of interest through multi-step organic synthesis
  • New chemical transformation optimization
  • Purification using HPLC and other automated methods
  • Compound characterization using NMR and MS data
  • Participate and contribute during scientific discussions, meetings, and presentations
  • Apply method development to parallel library synthesis strategies for rapid implementation by medicinal chemistry project teams
  • Writing up research reports that capture experimental data and progress
  • Contribute to a research effort that may be amenable to publication or public presentation

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs, providing affordable alternatives that maintain the same quality and safety standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while adhering to sustainability and corporate responsibility principles.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.